DocWire News Editors

DocwireNews

Recent research suggests that morbidly obese patients may be valid candidates for a total knee replacement, contrary to popular opinion. Risk of postoperative complications is commonly associated with increased patient BMI for reasons related to surgical exposure time, therefore those with morbid obesity are often viewed as poor candidates for a knee replacement. This new research, however, compared patient outcomes to find that those with morbid obesity may not experience severely different outcomes than their healthy counterparts. This work was published on August 2 in the journal <a href="https://link.springer.com/article/10.1007/s00264-019-04378-y">International Orthopaedics</a>.
<h2>Opinions on Knee Replacements in Obese Patients</h2>
Performing <a href="https://www.docwirenews.com/abstracts/orthopedic-abstracts/revision-rates-and-functional-outcomes-among-severely-morbidly-and-super-obese-patients-following-primary-total-knee-arthroplasty-a-systematic-review-and-meta-analysis/">knee arthroplasty</a> in an obese individual is technically a more challenging procedure, requiring more time and greater exposure for surgical access. <a href="https://bmcsportsscimedrehabil.biomedcentral.com/articles/10.1186/2052-1847-5-25">Previous research</a> has found that intra-operative complications, such as blood loss and difficulty identifying anatomy, are elevated in those with obesity. Being that obesity is becoming more prevalent in an aging population, the number of total knee replacements conducted in overweight patients is expected to rise.
Though this joint replacement is often the only remedy for severe osteoarthritis, physicians are often hesitant to operate on these patients due to their weight. To better understand total knee replacement outcomes in patients with obesity, this research team compared knee replacement outcomes between morbidly obese, obese, and non-obese patients.
<h2>Background of the Joint Replacement Study</h2>
Morbidly obese, obese, and non-obese patients were defined as having a BMI over 40 kg/m2, between 30 and 40 kg/m2, and under 30 kg/m2, respectively. The goal of this study was not only to compare the outcomes among patients in these three categories but to evaluate how individuals within the morbidly obese group fared as well. To do so, the researchers further broke this group into patients with morbid obesity (BMI between 40 and 50 kg/m2) and patients with extreme morbid obesity (BMI over 50 kg/m2). The team also aimed to present surgical tips that can improve knee replacement outcomes in patients with morbid obesity.
In <a href="https://www.docwirenews.com/abstracts/long-term-outcome-of-total-knee-arthroplasty-in-patients-with-morbid-obesity/">this work</a>, the researchers recruited 333 patients who underwent a knee replacement operation. 39 of them were lost at follow-up, resulting in a final patient population of 292 patients. 82 of these patients received total joint replacements in both knees and 374 received the knee replacement on one side only. The average age in this patient population was around 64 years of age, with an average follow-up of roughly 11 years. The knees were evaluated at follow-up for implant position, alignment, stability, pain, and other factors.
The research team found significant improvements in various knee scores in the non-obese, obese, and morbidly obese groups, with a significant change being observed between the obese and non-obese patients as compared to the morbidly obese population. No significant differences in outcomes were observed between those with morbid and extremely morbid obesity. The researchers did note a slight increase in the risk of early complications after the operation in patients with morbid obesity, including skin necrosis and infection.
Being that the morbidly obese patient population showed improved post-operative scores and no significant differences in outcomes within the group, the authors feel that these patients are viable candidates for total knee replacements.
“We believe that morbid obese patients are appropriate candidates and can enjoy the benefits of total knee arthroplasty done with careful use of some surgical tips presented in our study,” they concluded.
<h2>Author Affiliations</h2>
The lead author of the International Orthopaedics paper is Jeries Hakim, Department of Orthopedic Surgery at <a href="https://www.nazarethtrust.org/our-work/nazareth-hospital-emms/">Nazareth EMMS Hospital</a>. Other authors include EMMS Hospital’s Mahmud Amashah, Faris Alkeesh, Saker Khamaisy, Jamal Ownallah, Miri Cohen, and Gershon Volpin. Cohen and Volpin are also associated with the Faculty of Social Welfare and Health Sciences and the Center for Rehabilitation Research at the <a href="https://www.haifa.ac.il/index.php/en/">University of Haifa</a> in Israel.

Andrew Moreno

Genetic Classification Model Differentiates MDS Stem, Progenitor Cells from Healthy Bone Marrow

ASH 2024

Cecilia Brown

FDA Grants Breakthrough Therapy Designation to Sacituzumab Govitecan for Second-Line Treatment of ES-SCLC

Small Cell Lung Cancer

Genetic Study Uncovers Potential Therapy-Actionable Transcription Factors in MDS

Latest News

How Do Knee Replacements Fare in Morbidly Obese Patients?

Orthopedics

Recent research suggests that morbidly obese patients may be valid candidates for a total knee replacement, contrary to popular opinion. Risk of postoperative complications is ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe